Policy

Cardiovascular Assessment Policy

Pre-treatment, in-treatment and ongoing cardiovascular risk assessment for patients accessing medically supervised weight management

For Weight Loss ClinicRef BS-WEI-POL-002See a sample (PDF) →
£54.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This policy is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Purpose
  • 2. Scope
  • 3. Policy statement
  • 4. Definitions
  • 5. Cardiovascular assessment at initial consultation
  • 6. In-treatment cardiovascular monitoring
  • 7. Escalation and emergency response
  • 8. Roles and responsibilities
  • 9. Training and competency
  • 10. Records, monitoring and audit
  • 11. Related documents
  • 12. Version control and review
  • Appendix A: Baseline cardiovascular assessment checklist
  • Appendix B: Cardiovascular red-flag escalation guide
  • 13. Disclaimer

Legislation & standards it maps to

  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 - in particular Regulation 9 (Person-centred care), Regulation 11 (Need for consent), Regulation 12 (Safe care and treatment), Regulation 17 (Good governance) and Regulation 18 (Staffing)
  • Care Quality Commission (Registration) Regulations 2009
  • Human Medicines Regulations 2012 (as amended)
  • Medicines and Healthcare products Regulatory Agency (MHRA) guidance on GLP-1 receptor agonists and high-risk weight-loss medicines
  • General Pharmaceutical Council Standards for Pharmacy Professionals and Guidance for Prescribing High-Risk Medicines (2024)
  • General Medical Council Good Medical Practice (2024) and Good Practice in Prescribing and Managing Medicines and Medical Devices
  • National Institute for Health and Care Excellence (NICE) Clinical Guideline NG246 (Overweight and obesity management, 2025) and CG181 (Cardiovascular disease: risk assessment and reduction)
  • Data Protection Act 2018 and the UK General Data Protection Regulation (UK GDPR)

Who it applies to

All clinical and prescribing staff, healthcare professionals, clinical governance leads and supervising clinicians at [Organisation Name]

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Adverse drug reaction
A harmful or unintended response to a medicine taken at a normal dose.
Anticoagulant
A medicine that reduces the blood's ability to clot, sometimes called a blood thinner.
Antihypertensive
A medicine used to lower high blood pressure.
Arrhythmia
An abnormal heart rhythm, where the heart beats too fast, too slowly or irregularly.
Atrial fibrillation
A common type of irregular and often fast heart rhythm that can raise the risk of stroke.
Bariatric surgery
Weight-loss surgery, such as a gastric band or bypass, used to treat severe obesity.
Body mass index (BMI)
A measure of body weight in relation to height, used to gauge whether a person is underweight, a healthy weight or overweight.
Cardiovascular
Relating to the heart and blood vessels.
Cardiovascular assessment
A structured check of a person's heart and circulation history, measurements and tests to decide whether treatment is safe.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Contraindication
A specific situation or condition in which a treatment should not be used because it could be harmful.
Contemporaneous record
A note made at the time of, or very soon after, the event it describes.
Data Protection Act 2018
The UK law that governs how organisations collect, store and use people's personal information.
Decompensated heart failure
A sudden worsening of heart failure where the heart can no longer pump well enough to meet the body's needs.
Electrocardiogram (ECG)
A simple test that records the heart's electrical activity to check its rhythm and detect problems.
Fundamental standards
The minimum standards of safety and quality below which care must never fall.
General Medical Council (GMC)
The body that registers and regulates doctors in the United Kingdom.
General practitioner (GP)
A doctor based in the community who provides general medical care and coordinates a patient's overall health.
General Pharmaceutical Council (GPhC)
The body that registers and regulates pharmacists and pharmacies in Great Britain.
GLP-1 / GIP-GLP-1 receptor agonist
A class of medicines used for weight management and type 2 diabetes that reduce appetite and can affect heart rate and blood pressure.
HbA1c
A blood test that shows average blood glucose (sugar) levels over the previous two to three months.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting out the fundamental standards that providers of regulated health and care services must meet.
Heart failure
A long-term condition in which the heart cannot pump blood around the body as well as it should.
Hypercholesterolaemia
A higher than normal level of cholesterol in the blood, which raises cardiovascular risk.
Hypertension
Persistently raised blood pressure, which increases the risk of heart attack and stroke.
Hypertensive urgency
Very high blood pressure that needs prompt treatment but without immediate signs of organ damage.
Hypoglycaemia
An abnormally low level of glucose (sugar) in the blood.
Hypotension
Abnormally low blood pressure, which can cause dizziness or fainting.
Independent prescriber
A qualified health professional legally permitted to prescribe medicines on their own clinical judgement.
Informed consent
Agreement to treatment given freely after the risks, benefits and alternatives have been clearly explained.
Medicines and Healthcare products Regulatory Agency (MHRA)
The UK body that regulates medicines and medical devices and monitors their safety.
Medullary thyroid carcinoma
A rare type of thyroid cancer that is relevant when deciding whether certain weight-loss medicines are safe to use.
mmHg (millimetres of mercury)
The unit used to measure blood pressure.
Multiple Endocrine Neoplasia syndrome type 2
A rare inherited condition that increases the risk of certain tumours, including thyroid cancer.
Myocardial infarction
A heart attack, caused when blood flow to part of the heart muscle is blocked.
National Institute for Health and Care Excellence (NICE)
The body that produces evidence-based guidance on treatments and care for use across health and social care.
Nominated Individual
The senior person responsible to the regulator for supervising how a service is provided.
Orthopnoea
Breathlessness that occurs when lying flat and is eased by sitting or standing up.
Palpitations
An awareness of the heart beating, which may feel fast, irregular or unusually strong.
Pancreatitis
Inflammation of the pancreas, which can be triggered or worsened by some medicines.
Peripheral arterial disease
Narrowing of the arteries that reduces blood flow to the limbs, usually the legs.
Pharmacist independent prescriber
A pharmacist who is qualified to prescribe medicines on their own clinical judgement.
QRISK3
A validated calculation that estimates a person's risk of heart disease or stroke over the next ten years.
QT interval / QT prolongation
A measure of part of the heart's electrical cycle; when prolonged it can raise the risk of a dangerous heart rhythm.
Red flag
A symptom or finding that signals possible serious illness and prompts treatment to be withheld and urgent review.
Registered Manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulated activity
A type of care or treatment the law requires a provider to register with the regulator to deliver.
Single assessment framework
The structure the regulator uses to judge a service, built around quality statements and five key questions (safe, effective, caring, responsive and well-led).
Supervising clinician
The named, suitably qualified clinician who keeps overall clinical responsibility for a patient's treatment and monitoring.
Syncope
A temporary loss of consciousness, commonly known as fainting.
Tachycardia
An abnormally fast resting heart rate, generally over 100 beats per minute.
Transient ischaemic attack
A brief interruption of blood supply to the brain, sometimes called a mini-stroke, with symptoms that resolve quickly.
UK General Data Protection Regulation (UK GDPR)
The UK's main data-protection law governing how personal information is collected and used.
Unstable angina
Chest pain from the heart that occurs unpredictably or at rest and may signal an imminent heart attack.
Valvular disease
A condition in which one or more of the heart valves does not work properly.
Very-low-calorie diet (VLCD)
A diet providing very few calories (typically under 800 per day) that needs careful medical monitoring.
Yellow Card scheme
The UK system for reporting suspected side effects of medicines and problems with medical devices to the regulator.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyGLP-1 Prescribing Policy£54.99
PolicyPsychological Screening Policy£54.99
PolicyInformed Consent Policy£54.99
PolicyEating Disorder Safeguarding Policy£54.99

Need the whole set?

Buy the full Weight Loss Clinic pack and save versus buying documents individually.

View the Weight Loss Clinic pack